Amanda Mcquery News Today

- Sponsor of the Heart of Genetic Counseling program and award, recognizing excellence in patient care - - These studies combined with new digital tools aim to increase access and frequency of...

/PRNewswire/ -- Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, are showcasing their work next week at the National Society of...

– First-of-its-kind authorization provides potential marketing differentiation and opportunities for largest testing category – – Testament to Invitaes product and lab quality –  – Sets...

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced findings from its PROCLAIM trial, published in European Urology...

– Report details the companys commitment to improve healthcare for all through its ESG and sustainability initiatives – SAN FRANCISCO, April 17, 2023 /PRNewswire/ -- Invitae , a... | April 17, 2023

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today published its 2023 Environmental, Social and Governance (ESG) Report. This...

– Highlights the use of Invitaes personalized cancer monitoring technology to correlate clinical outcomes with minimal residual disease presence – – The analysis demonstrates... | April 13, 2023

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of W. Michael Korn, M.D., as its chief medical...

/PRNewswire/ -- Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, are presenting research next week at the National Society of Genetic...

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to use Invitaes...